当前位置: X-MOL 学术 › Microbiology Australia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Contextualising SARS Coronavirus 2 and COVID-19
Microbiology Australia Pub Date : 2021-04-26 , DOI: 10.1071/ma21002
William Rawlinson

It is timely to assess where we are in the current SARS Coronavirus-2 pandemic. This edition of Microbiology Australia has national, and international, authorities authoring a series of papers on SARS Coronavirus 2 and related subjects. We are extremely fortunate to have papers on the overarching issues of zoonotic spread (Gartner, Selleck) and how this relates to the practicalities of our responses via public health (Bennett), vaccination (Macintyre), antivirals (De Clercq), and immunotherapies (Kelleher). Diagnosis and transmission control have been at the centre of public health responses (Blackall, Speers), as has been research informing our understanding of the virus (Dhakal, Zaunders, Eden). A focus on basic research, translated into outcomes in real time, has been a very successful feature of the COVID-19 pandemic. We are privileged to be able to feature some of this research, in these papers, although this is only part of the extensive and excellent Australian work in reducing the impact of SARS CoV2 infection, and COVID-19 disease.



中文翻译:

情景化SARS冠状病毒2和COVID-19

现在应该评估我们目前在SARS冠状病毒2大流行中所处的位置。此版《澳大利亚微生物学》拥有国家和国际权威,撰写了一系列有关SARS冠状病毒2及其相关主题的论文。我们非常幸运地收到有关人畜共患病传播的主要问题的论文(Gartner,Selleck),以及这与我们通过公共卫生(Bennett),疫苗接种(Macintyre),抗病毒药(De Clercq)和免疫疗法( Kelleher)。诊断和传播控制一直是公共卫生对策的重点(Blackall,Speers),而研究工作已经使我们对病毒有了更深入的了解(Dhakal,Zaunders,Eden)。专注于基础研究并实时转换为结果已成为COVID-19大流行的一个非常成功的特征。

更新日期:2021-04-30
down
wechat
bug